Genetic Alterations and Personalized Medicine in Melanoma: Progress and Future Prospects
نویسندگان
چکیده
منابع مشابه
Progress towards personalized medicine.
Personalized medicine is the tailoring of therapies to defined subsets of patients based on their likelihood to respond to therapy or their risk of adverse events. The advent of improved genomic tools has greatly hastened our understanding of the molecular pathology of diseases, enabling us to redefine disease at the molecular level. The development of molecularly targeted therapies, coupled wi...
متن کاملMalignant melanoma--future prospects.
As the incidence and already high mortality rates of malignant melanoma have been steadily increasing in recent decades, the early detection and excision of malignant melanoma have imposed as the most important task. Staging of malignant melanoma is determined according to the level of invasion (Clark level) and vertical thickness (Breslow scale). Besides operative therapy, which is the only ef...
متن کاملProspects for Personalized Cardiovascular Medicine
Sequencing of the human genome has ushered in prospects for individualizing cardiovascular health care. There is growing evidence that the practice of cardiovascular medicine might soon have a new toolbox to predict and treat disease more effectively. The Human Genome Project has spawned several important “omic” technologies that allow “whole genome” interrogation of sequence variation (re-sequ...
متن کاملMicropumps—past, progress and future prospects
If a high and on-going research dynamics is taken as a rejuvenating factor microfluidics can still be regarded as a truly young discipline, although some microfluidic devices definitely can not be considered as “youngsters” any more. In a time of 30 years of ISFETOLOGY it may be worth to take a look at these devices in order to examine, whether they had—and still have—the potential to stimulate...
متن کاملDown syndrome—recent progress and future prospects
Down syndrome (DS) is caused by trisomy of chromosome 21 (Hsa21) and is associated with a number of deleterious phenotypes, including learning disability, heart defects, early-onset Alzheimer's disease and childhood leukaemia. Individuals with DS are affected by these phenotypes to a variable extent; understanding the cause of this variation is a key challenge. Here, we review recent research p...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JNCI Journal of the National Cancer Institute
سال: 2014
ISSN: 0027-8874,1460-2105
DOI: 10.1093/jnci/djt435